Effect of eugenol on animal models of nociception

Indian Journal of Pharmacology

Volumn 38, Issue 5, 2006, Pages 341-345

  Kurian, R ^a   Arulmozhi, D K ^a,b   Veeranjaneyulu, A ^a   Bodhankar, S L ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Antinociceptive; Clove oil; Pain models

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; ACETIC ACID; DEXTROMETHORPHAN; DIAZEPAM; EUGENOL; INDOMETACIN; KETAMINE; MEMANTINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTAZOCINE; POLYSORBATE 80;

ABDOMINAL WALL MUSCULATURE; ADOLESCENT; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HYPERALGESIA; INFLAMMATION; LATENT PERIOD; MALE; MOTOR COORDINATION; MOUSE; MUSCLE CONTRACTION; NOCICEPTION; NONHUMAN; PAIN; SEDATION;

EID: 33749634684     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.27702     Document Type: Article

References (27)

1. Prakash P, Gupta N. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian J Physiol Pharmacol 2005;49:725-31.
2. Irie Y, Itokazu N, Anjiki N, Ishige A, Watanabe K, Keung WM. Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus. Brain Res 2004;1011:243-6.
3. Dallmeier Zelger KR, Zelger JL, Carlini EA. New anticonvulsants derived from 4-allyl-2-methoxyphenol (Eugenol): Comparison with common antiepileptics in mice. Pharmacology 1983;27:40-9.
4. Sell AB, Carlini EA. Anesthetic action of methyleugenol and other eugenol derivatives. Pharmacology 1976;14:367-77.
5. Ko FN, Liao CH, Kuo YH, Lin YL. Antioxidant properties of demethyldiisoeugenol. Biochim Biophys Acta 1995;1258:145-52.
6. Dohi T, Anamura S, Shirakawa M, Okamoto H, Tsujimoto A. Inhibition of lipoxygenase by phenolic dental medicaments. Jpn J Pharmacol 1991;55:547-50.
7. Santos ARS, Filhe VC, Niero R, Viana AM, Moreno FN, Campos MM, et al. Analgesic effects of callus culture from selected species of Phyllanthus. J Phar Pharmacol 1994;46:755-9.
8. Hunskaar S, Hole K. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain 1987;30:103-14.
9. Eddy NB, Leimbach D. Synthetic analgesics: II. Dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 1953;107:385-93.
10. Perez, GRM, Perez LJA, Garcia DLM, Sossa MH. Neuropharmacological activity of Solanum nigrum fruit. J Ethnopharmacol 1998;62:43-8.
11. Ahmed M, Amin S, Islam M, Takahashi M, Okuyama E, Hossain CF. Analgesic principle from Abutilon indicum. Pharmazie 2000;55:314-6.
12. Ohkubo T, Shibata M. The selective capsaicin antagonist capsazepine abolishes the antinociceptive action of eugenol and guaiacol. J Dent Res 1997;76:848-51.
13. Amico-Roxas M, Caruso A, Trombadore S, Scifo R, Scapagini U. Gangliosides antinociceptive effects in rodents. Arch Int Pharmacodyn Ther 1984;272:103-117.
14. Raj PP. Pain mechanism. In: Raj PP, editor. Pain medicine: A comprehensive review. 1st ed. Missouri: Mosby-Year Book; 1996. p.12-23.
15. Fields HL. Analgesic drugs. In: Day W, editor. Pain. 1st ed. USA: Mac-Graw-Hill; 1987. p. 272.
16. Kim SS, Oh OJ, Min HY, Park EJ, Kim Y, Park HJ et al. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci 2003;73:337-48.
17. Murakami Y, Shoji M, Hirata A, Tanaka S, Yokoe I, Fujisawa S. Dehydroisoeugenol, an isoeugenol dimer, inhibits lipopolysaccharide-stimulated nuclear factor kappa B activation and cyclooxygenase-2 expression in macrophages. Arch Biochem Biophys 2005;434:326-32.
18. Abbot FV, Franklin KB, Westbrook RF. The formalin test scoring properties of the first and second phase of the pain response in rats. Pain 1995;60:91-102.
19. Davidson EM, Carlton SM. Intraplantar injection of dextrophan, ketamine or memantine attenuates formalin induced behaviors. Brain Res 1998;785:136-42.
20. Eisenberg E, Vos BP, Strassman AM. The NMDA antagonist memantine blocks pain behavior in a rat model of formalin induced facial pain. Pain 1993;54:301-7.
21. Berrino L, Oliva P, Massimo F, Aurilio C, Maione S, Grella A. Antinociceptive effect in mice, of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur J Pain 2003;7:131-57.
22. Brodin P. Differential inhibition of A, B, and C fibres in the rat vagus nerve by lidocanine, eugenol and formaldehyde. Arch Oral Biol 1985;30:477-80.
23. Sensch O, Vierling W, Brandt W, Reiter M. Effects of inhibition of calcium and potassium currents in guinea-pig cardiac contraction: comparision of β-caryophyllene oxide, eugenol and nifedipine. Br J Pharmacol 2000;131:1089-96.
24. Lee MH, Yeon KY, Park CK, Li HY, Fang Z, Kim MS, et al. Eugenol inhibits calcium currents in dental afferent neurons. J Dent Res 2005;84:848-51.
25. Yang BH, Piao ZG, Kim YB, Lee CH, Park K, Kim JS, et al. Activation of vanilloid receptor (VR1) by eugenol. J Dent Res 2003;82:781-85.
26. Ohkubo T, Shibata M. The selective capsaicin antagonist capsazepine abolishes the antinociceptive action of eugenol and guaiacol. J Dent Res 1997;76:848-51.
27. Janssen PAJ, Niememegeers CJ, Dony GH. The inhibitory effects of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneimittelforschung 1963;13:502-7.